Phoenix Nest Inc.
Rising Up To Meet The Challenge
New York, United States · Founded 2016 · $1.7M raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- phoenixnestbiotech.com
- Total Funding
- $1.7M
- Last Round
- $1.7M GrantJan 2020
About
Phoenix Nest is a niche biotech company focused on developing treatments for Sanfilippo syndrome, an ultra-rare and fatal pediatric neurodegenerative disease. Founded by parents of affected children, the company advances gene therapy, chaperone therapy, and enzyme replacement therapy for MPS IIIB, IIIC, and IIID subtypes through NIH-funded research collaborations and academic partnerships.
Summary
Phoenix Nest Inc. is a Biotech company based in New York, United States, founded in 2016. It has raised $1.7M in total, most recently a $1.7M Grant round in Jan 2020.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company

Specialty pharmaceutical company